Recombinant Bordetella-Pertussis Pertactin (P69) From The Yeast Pichia-Pastoris - High-Level Production And Immunological Properties
UTSePress Research/Manakin Repository
JavaScript is disabled for your browser. Some features of this site may not work without it.
- UTSePress Research Home
- >
- 11 Medical and Health Sciences
- >
- Journal Articles
- >
- Closed
- >
- View Item
| dc.contributor.author | Romanos Ma | en_US |
| dc.contributor.author | Clare Jj | en_US |
| dc.contributor.author | Beesley Km | en_US |
| dc.contributor.author | Rayment Fb | en_US |
| dc.contributor.author | Ballantine Sp | en_US |
| dc.contributor.author | Makoff Aj | en_US |
| dc.contributor.author | Dougan G | en_US |
| dc.contributor.author | Fairweather Nf | en_US |
| dc.contributor.author | Charles Ian | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2011-02-07T06:24:25Z | |
| dc.date.available | 2011-02-07T06:24:25Z | |
| dc.date.issued | 1991 | en_US |
| dc.identifier | 2009002891 | en_US |
| dc.identifier.citation | Romanos Ma et al. 1991, 'Recombinant Bordetella-Pertussis Pertactin (P69) From The Yeast Pichia-Pastoris - High-Level Production And Immunological Properties', Butterworth-Heinemann Ltd, vol. 9, no. 12, pp. 901-906. | en_US |
| dc.identifier.issn | 0264-410X | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/13749 | |
| dc.description.abstract | Acellular whooping cough vaccines are based on pertussis toxoid but their effectiveness may be increased by the addition of other Bordetella pertussis antigens. We expressed the immunogenic outer membrane protein pertactin (P69) from B. pertussis to hig | en_US |
| dc.language | en_US | |
| dc.publisher | Butterworth-Heinemann Ltd | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1016/0264-410X(91)90011-T | en_US |
| dc.title | Recombinant Bordetella-Pertussis Pertactin (P69) From The Yeast Pichia-Pastoris - High-Level Production And Immunological Properties | en_US |
| dc.parent | Vaccine | en_US |
| dc.journal.volume | 9 | en_US |
| dc.journal.number | 12 | en_US |
| dc.publocation | Oxford | en_US |
| dc.identifier.startpage | 901 | en_US |
| dc.identifier.endpage | 906 | en_US |
| dc.cauo.name | SCI.Medical and Molecular Biosciences | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 110700 | en_US |
| dc.personcode | 0000060172;0000060173;0000060174;0000060175;0000060160;0000060158;0000060138;0000060145;109028 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Immunology | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:A1991GQ32600011 | en_US |
| dc.description.keywords | en_US | |
| dc.staffid | en_US |
